Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 11, Issue 1, Pages 27-37
http://dx.doi.org/10.1155/S1064744903000048

Ertapenem Once a Day Versus Piperacillin–Tazobactam Every 6 Hours for Treatment of Acute Pelvic Infections: A Prospective, Multicenter, Randomized, Double-Blind Study

1Keck School of Medicine at USC, Los Angeles, CA, USA
2Nuevo Hospital Civil, Guadalajara, Mexico
3Universidad Nacional de Colombia, Bogota, Colombia
4University of Chicago, Chicago, IL, USA
5Merck Research Laboratories, West Point, PA, USA
6Merck &Co., Inc., 10 Sentry Parkway, BL 3-4, Blue Bell, PA 19422, USA

Received 26 June 2002; Accepted 14 October 2002

Copyright © 2003 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Subir Roy, Iliana Higareda, Edith Angel-Muller, et al., “Ertapenem Once a Day Versus Piperacillin–Tazobactam Every 6 Hours for Treatment of Acute Pelvic Infections: A Prospective, Multicenter, Randomized, Double-Blind Study,” Infectious Diseases in Obstetrics and Gynecology, vol. 11, no. 1, pp. 27-37, 2003. https://doi.org/10.1155/S1064744903000048.